Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/19/2012CA2814135A1 Compositions for treating psoriasis of the scalp
04/19/2012CA2814097A1 Composition for treating cancer by the controlled release of an active substance
04/19/2012CA2814092A1 Metal complexes of n-heterocyclic carbenes
04/19/2012CA2814076A1 Nucleic acid modulators of clec-2
04/19/2012CA2814011A1 Salts of arylsulfonamide ccr3 antagonists
04/19/2012CA2813936A1 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof
04/19/2012CA2813908A1 Aryloxyurea compound and pest control agent
04/19/2012CA2813838A1 Process for manufacturing dihydropteridinones and intermediates thereof
04/19/2012CA2813783A1 Methods and compositions for inhibition of polymerase
04/19/2012CA2813781A1 Pharmaceutical compositions containing a dgat1 inhibitor
04/19/2012CA2813750A1 Method for treating cystic fibrosis with inhaled denufosol
04/19/2012CA2813743A1 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
04/19/2012CA2813711A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/19/2012CA2813648A1 Combinations of serotonin receptor agonists for treatment of movement disorders
04/19/2012CA2813555A1 Methods for treating hyperuricemia and related diseases
04/19/2012CA2813520A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012CA2813510A1 Curcuminoid solid dispersion formulation
04/19/2012CA2813163A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012CA2812779A1 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
04/19/2012CA2812657A1 A method of regulating plasma lipoproteins
04/19/2012CA2812417A1 Cationic dry powders
04/19/2012CA2811752A1 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
04/19/2012CA2811641A1 Serotonin reuptake inhibitors
04/19/2012CA2811583A1 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol
04/19/2012CA2810999A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
04/19/2012CA2810900A1 Methods for inhibiting cell proliferation in egfr-driven cancers
04/19/2012CA2809966A1 Treatment for cocaine addiction
04/18/2012EP2441847A2 Screening methods using syk in combination with tau protein
04/18/2012EP2441836A1 Compound inhibiting TP53INP1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods
04/18/2012EP2441835A1 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
04/18/2012EP2441833A1 Aptamer for chymase, and use thereof
04/18/2012EP2441779A1 Process for the preparation of sevelamer hydrochloride and formulation thereof
04/18/2012EP2441768A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers
04/18/2012EP2441767A1 Salinosporamides and methods for use thereof
04/18/2012EP2441766A1 Nalmefene hydrochloride dihydrate
04/18/2012EP2441763A1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
04/18/2012EP2441762A1 Potentiators of Glutamate Receptors
04/18/2012EP2441760A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
04/18/2012EP2441757A1 Aurora kinase inhibitors from an encoded small molecule library
04/18/2012EP2441755A1 Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
04/18/2012EP2441753A1 Tetracyclic compound
04/18/2012EP2441464A1 Specific therapy and medicament using integrin ligands for treating cancer
04/18/2012EP2441463A1 Alkaline decomposition product of hop extract and use thereof
04/18/2012EP2441459A1 5'-methylthioadenosine neuroprotective properties
04/18/2012EP2441458A1 A vascular protecting agent having salt-absorption inhibitory activity
04/18/2012EP2441457A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
04/18/2012EP2441456A1 DHEA compositions for treating menopose
04/18/2012EP2441455A1 Methods of administering pirfenidone therapy
04/18/2012EP2441454A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer
04/18/2012EP2441453A1 Pharmaceutical composition for use in medical and veterinary ophthalmology
04/18/2012EP2441452A1 Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
04/18/2012EP2441451A1 Coccidiosis control agent and feed containing same
04/18/2012EP2441450A1 Antioxidant composition for reducing the oxidative stress and side effects ascribable to treatment with levothyroxine
04/18/2012EP2441449A1 Modulation of apolipoprotein C-III expression
04/18/2012EP2441448A1 Gum resin as a carrier for topical application of pharmacologically active agents
04/18/2012EP2441446A1 Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
04/18/2012EP2441445A1 Coating of cetyl myristate and/or cetyl palmitate particles
04/18/2012EP2441444A1 Formulations of cetyl myristate and/or cetyl palmitate
04/18/2012EP2441442A1 A pharmaceutical composition comprising a thiazolidinedione
04/18/2012EP2441441A1 A sieving method for cetyl myristate and/or cetyl palmitate
04/18/2012EP2441438A1 Sachet formulations of eslicarbazepine
04/18/2012EP2441433A1 Composition containing microbial zeaxanthin and preparation thereof
04/18/2012EP2440921A1 Therapeutic agent and assay
04/18/2012EP2440660A2 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
04/18/2012EP2440567A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
04/18/2012EP2440563A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
04/18/2012EP2440560A1 The succinate of tenofovir disoproxil
04/18/2012EP2440559A2 Egfr inhibitors and methods of treating disorders
04/18/2012EP2440558A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
04/18/2012EP2440556A1 Inhibitors of phosphatidylinositol 3-kinase
04/18/2012EP2440555A1 Fluorinated aminotriazole derivatives
04/18/2012EP2440554A1 Pyrazole oxadiazole derivatives as s1p1 agonists
04/18/2012EP2440553A1 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
04/18/2012EP2440551A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
04/18/2012EP2440550A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
04/18/2012EP2440549A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
04/18/2012EP2440548A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
04/18/2012EP2440547A2 Compounds useful for treating aids
04/18/2012EP2440546A2 Compounds useful for treating premature aging and in particular progeria
04/18/2012EP2440545A2 Compounds useful for treating cancer
04/18/2012EP2440544A1 Hedgehog pathway antagonists and therapeutic applications thereof
04/18/2012EP2440543A2 Improved method for synthesizing pirfenidone
04/18/2012EP2440542A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
04/18/2012EP2440541A1 Novel fused cyclic compound and use thereof
04/18/2012EP2440537A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
04/18/2012EP2440536A1 Oxazole and thiazole derivatives as alx receptor agonists
04/18/2012EP2440535A1 Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
04/18/2012EP2440534A2 Pyrimidine derivatives as zap-70 inhibitors
04/18/2012EP2440533A1 Guanine riboswitch binding compounds and their use as antibiotics
04/18/2012EP2440529A1 Janus kinase inhibitor compounds and methods
04/18/2012EP2440528A1 Heterocyclic antiviral compounds
04/18/2012EP2440527A1 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
04/18/2012EP2440525A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
04/18/2012EP2440523A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
04/18/2012EP2440521A1 Novel cyclopentane derivatives
04/18/2012EP2440519A1 Alkanoylamino benzamide aniline hdac inihibitor compounds
04/18/2012EP2440517A2 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
04/18/2012EP2440295A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2440294A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2440250A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
1 ... 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 ... 7860